Nexomics Biosciences
Biotechnology, Rocky Hill, New Jersey, 33694, United States, 1-10 Employees
Phone Number: +18*********
Who is NEXOMICS BIOSCIENCES
Nexomics Biosciences focuses on the discovery, development and commercialization of novel drugs focusing on cancer, antiviral and antibiotic treatments. Nexomics Biosciences also function...
Read More
-
Headquarters: Rocky Hill, New Jersey, 33694, United States
-
Date Founded: 2007
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Rong Xiao
Email
Phone
Industry: Biotechnology
NAICS Code: 541712 |
Show More
Does something look wrong? Fix it. | View contact records from NEXOMICS BIOSCIENCES
Nexomics Biosciences Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nexomics Biosciences
Answer: Nexomics Biosciences's headquarters are located at Rocky Hill, New Jersey, 33694, United States
Answer: Nexomics Biosciences's phone number is +18*********
Answer: Nexomics Biosciences's official website is https://nexomics.com
Answer: Nexomics Biosciences's revenue is $10 Million to $25 Million
Answer: Nexomics Biosciences's NAICS: 541712
Answer: Nexomics Biosciences has 1-10 employees
Answer: Nexomics Biosciences is in Biotechnology
Answer: Nexomics Biosciences contact info: Phone number: +18********* Website: https://nexomics.com
Answer: Nexomics Biosciences focuses on the discovery, development and commercialization of novel drugs focusing on cancer, antiviral and antibiotic treatments. Nexomics Biosciences also functions as a contract research organization (CRO), offering a broad array of gene-to-structure services to the biopharmaceutical community. We offer a variety of services from bioinformatics target profiling, gene cloning, recombinant protein expression, laboratory-scale fermentation, crystallization, NMR structural studies, X-ray crystallography structural studies, assay development, and functional annotation. Nexomics Biosciences aims to build a portfolio of intellectual property associated with structure-based assay development, protein production, and drug discovery. Our long term goal is development of a proprietary pharmaceutical discovery program based on characterizing disease related proteins and their molecular functions, and by identifying potential drug target binding compounds.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month